Overview

This trial is active, not recruiting.

Condition amyotrophic lateral sclerosis
Sponsor Klinikum Ludwigshafen
Start date October 2009
End date September 2012
Trial size 200 participants
Trial identifier NCT01955369, 837.253.09

Summary

There is a lack of prospective and population-based epidemiological data on amyotrophic lateral sclerosis in Germany so far. The purpose of this registry is to investigate the incidence, course and phenotypic variety of ALS in Rhineland-Palatinate, a South-West German state of about 4 million inhabitants.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Arm
Patients were included into the registry if they had a new diagnosis of ALS, a minimum age of 18 years and lived in Rhineland-Palatinate for at least 6 months before date of diagnosis. Diagnosis was based upon the revised El Escorial criteria.

Primary Outcomes

Measure
Death
time frame: minimum of three years

Secondary Outcomes

Measure
Tracheostomy
time frame: minimum of three years

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - diagnosis of amyotrophic lateral sclerosis according to revised El Escorial criteria - minimum of 18 years - minimum of 6 months of residency in Rhinelnad-Palatinate Exclusion Criteria: - patients below 18 years - ALS patients outside Rhineland-Palatinate

Additional Information

Official title Amyotrophic Lateral Sclerosis Registry Rhineland-Palatinate
Principal investigator Joachim Wolf, Dr
Trial information was received from ClinicalTrials.gov and was last updated in April 2015.
Information provided to ClinicalTrials.gov by Klinikum Ludwigshafen.